Differentiated Thyroid Cancer: A Health Economic Review
Autor: | Fausto Palazzo, Klaas Van Den Heede, Neil Tolley, Aimee Di Marco |
---|---|
Rok vydání: | 2021 |
Předmět: |
Cancer Research
medicine.medical_specialty 030209 endocrinology & metabolism Review medical Asymptomatic 03 medical and health sciences 0302 clinical medicine Health care medicine Overdiagnosis Intensive care medicine Thyroid cancer RC254-282 Health economics Cost–benefit analysis thyroid neoplasms business.industry cost-benefit analysis Incidence (epidemiology) Thyroid Neoplasms. Tumors. Oncology. Including cancer and carcinogens economics medicine.disease medicine.anatomical_structure Oncology 030220 oncology & carcinogenesis medicine.symptom business |
Zdroj: | Cancers Cancers, Vol 13, Iss 2253, p 2253 (2021) |
ISSN: | 2072-6694 |
Popis: | Simple Summary This review reflects on health economic considerations associated with the increasing diagnosis and treatment of differentiated thyroid cancer. Analysis of different relevant health economic topics, such as overdiagnosis, overtreatment, surgical costs, and costs of follow-up are being addressed. Several unanswered research questions such as optimising molecular markers for diagnosis, active surveillance of primary tumours, and improved risk stratification and survivorship care all influence future healthcare expenditures. Abstract The incidence of differentiated thyroid cancer (DTC) is rising, mainly because of an increased detection of asymptomatic thyroid nodularity revealed by the liberal use of thyroid ultrasound. This review aims to reflect on the health economic considerations associated with the increasing diagnosis and treatment of DTC. Overdiagnosis and the resulting overtreatment have led to more surgical procedures, increasing health care and patients’ costs, and a large pool of community-dwelling thyroid cancer follow-up patients. Additionally, the cost of thyroid surgery seems to increase year on year even when inflation is taken into account. The increased healthcare costs and spending have placed significant pressure to identify potential factors associated with these increased costs. Some truly ground-breaking work in health economics has been undertaken, but more cost-effectiveness studies and micro-cost analyses are required to evaluate expenses and guide future solutions. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |